<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Several bioethics challenges can rise with the establishment of transplantation laws and norms in order to respect the bioethics principles (Beauchamp and Childress 
 <xref ref-type="bibr" rid="CR9">2001</xref>), such as gratuity (Council of Europe 
 <xref ref-type="bibr" rid="CR24">2018</xref>) as matter of justice, informed consent as part of autonomy, confidentiality has repercussions in the principles of autonomy and no maleficence and finally the quality of tissue that has direct implications in no malificency (Erk 
 <xref ref-type="bibr" rid="CR34">2012</xref>; Report from the Nuffield Council on Bioethics 
 <xref ref-type="bibr" rid="CR70">2020</xref>).
 <xref ref-type="fn" rid="Fn2">2</xref> We summarised the main four sub-categories in TableÂ 
 <xref rid="Tab1" ref-type="table">1</xref>, stating the considerations that need to be taken into account for tissue transplant services before any human-derived manufacturing can occur.
</p>
